Early Versus Delayed Usage of Paxlovid in Severe Omicron‐Infected Patients With Hypoxemia: A Prospective Multiple‐Center Cohort Study
In Omicron-infected subjects with hypoxemia, early usage of Paxlovid received benefits in hospitalized time and viral clearance, but delayed usage did not result in a worse composite prognosis. This result might provide direct evidence of antiviral strategy in severe Omicron infection subjects with hypoxemia.
Authors
- M T Zhang
- Xiaoying Wei
- Ran Wang (ORCID: https://orcid.org/0000-0002-3016-1011)
- Yuji Wang (ORCID: https://orcid.org/0000-0002-2614-4593)
- Nan Su (ORCID: https://orcid.org/0000-0002-4564-1595)
- Guifang Xu (ORCID: https://orcid.org/0000-0001-9949-3658)
- Daxiong Zeng (ORCID: https://orcid.org/0000-0002-6476-2974)
- Xiao Ma (ORCID: https://orcid.org/0000-0002-2920-4475)
- Jun‐Hong Jiang (ORCID: https://orcid.org/0000-0003-2933-1084)
Institutions
- Anhui Medical University (CN)
- Soochow University (CN)
- Suzhou Municipal Hospital (CN)
- Second Affiliated Hospital of Soochow University (CN)
- First Affiliated Hospital of Soochow University (CN)
- The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Health Science Reports
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1002/hsr2.70177
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00